Open AccessEvaluation of prescriptions of medicines not included in Iran medicine list: A cross-sectional study
Author(s) -
Marzieh Zargaran,
Shekoufeh Nikfar,
Abdol Majid Cheraghali
Publication year - 2016
Publication title -
journal of research in pharmacy practice
Language(s) - English
Resource type - Journals
eISSN - 2319-9644
pISSN - 2279-042X
DOI - 10.4103/2279-042x.192456
Subject(s) - medicine , cross sectional study , medical prescription , traditional medicine , alternative medicine , family medicine , pharmacology , pathology
Iran Food and Drug Administration (IFDA) has the mission to regulate all aspects of pharmaceutical market including registration of the new medicines. Iran Drug Selection Committee has the responsibility to maintain and revise Iran Medicine List (IML). The National law has banned production, importation, distribution, and prescription of medicines not included in IML. Although, IFDA policy makers have created a mechanism to provide medicines not included in the list but might be essential for the treatment of specific patients.